Harvest Group Wealth Management, LLC Cytosorbents Corp Transaction History
Harvest Group Wealth Management, LLC
- $154 Million
- Q1 2023
A detailed history of Harvest Group Wealth Management, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Harvest Group Wealth Management, LLC holds 37 shares of CTSO stock, worth $48. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37
Previous 37
-0.0%
Holding current value
$48
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CTSO
# of Institutions
55Shares Held
16.9MCall Options Held
10.1KPut Options Held
500-
Avenir Corp Washington, DC2.97MShares$3.92 Million0.21% of portfolio
-
Skylands Capital, LLC2.84MShares$3.75 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.66MShares$3.52 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.57 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.54MShares$2.03 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $57.5M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...